Paul Jones
individual
About
Paul Jones is a UK-based life-sciences executive and commercialization operator who became CEO of Vortex Biotech Holdings in 2022. Earlier, he led population genomics at Illumina and was the founding CEO of Genomics Enterprises, the commercial arm of Genomics England's 100,000 Genomes Project. Public bios also describe him as a Venture Partner working across the NetScientific portfolio, with a focus on affordable population health, genomics, and oncology innovation.
Areas of interest
genomicspopulation healthprecision medicineoncologyliquid biopsycirculating tumor cellsbiotech commercializationlife scienceshealthcare innovation